Ranbaxy Of India To Recall Anticholesterol Drug Batches In U.K.
This article was originally published in PharmAsia News
Executive Summary
India's Ranbaxy Laboratories said it was recalling batches of its pravastatin pills from the United Kingdom because of a failure to comply with warning-label rules